← Open Payments lookup

ADIB KASSAS: Open Payments

NPI 1386694156 · DUBUQUE, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$358 in 20 payments from 9 companies in 2025. Trend: 2023 $206 · 2024 $244 · 2025 $358

Food & beverage: $358
CompanyPaymentsAmount
ABBVIE INC.5$82
Otsuka America Pharmaceutical, Inc.3$62
Neurocrine BioSciences, Inc.3$52
Axsome Therapeutics, Inc.2$42
ACADIA Pharmaceuticals Inc2$33
E.R. Squibb & Sons, L.L.C.2$29
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$21
Supernus Pharmaceuticals, Inc.1$19
Teva Pharmaceuticals USA, Inc.1$19

Products named: VRAYLAR, REXULTI, INGREZZA, Sunosi, NUPLAZID, COBENFY, CAPLYTA, Qelbree.

Industry payments across IA — which companies pay providers there.